{"id":753772,"date":"2023-05-02T14:42:45","date_gmt":"2023-05-02T18:42:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"modified":"2023-05-02T14:42:45","modified_gmt":"2023-05-02T18:42:45","slug":"fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","title":{"rendered":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, May  02, 2023  (GLOBE NEWSWIRE) &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in\u00a0<strong>Fulcrum Therapeutics, Inc. <\/strong>(\u201cFulcrum\u201d or the &#8220;Company&#8221;)\u00a0(NASDAQ: FULC) of a class action securities lawsuit.<\/p>\n<p>The lawsuit on behalf of Fulcrum Therapeutics, Inc. investors has been commenced in the United States District Court for New Jersey. Affected investors purchased or otherwise acquired certain Fulcrum securities\u00a0<strong><u>between March 3, 2022 and March 8, 2023<\/u><\/strong>. Follow the link below to get more information and be contacted by a member of our\u00a0team:<\/p>\n<p>\n        <a href=\"https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3<\/a>\n      <\/p>\n<p>or contact Joseph E. Levi, Esq. either via email at\u00a0<a href=\"mailto:jlevi@levikorsinsky.com\" rel=\"nofollow noopener\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.\u00a0<strong>There is no cost or obligation to you.<\/strong><\/p>\n<p>\n        <strong>Fulcrum Therapeutics, Inc. NEWS \u2013 FULC NEWS<\/strong>\n      <\/p>\n<p>\n        <strong>CASE DETAILS:<\/strong>\u00a0According to the filed complaint, during the class period, Fulcrum made materially false and\/or misleading statements and\/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058\u2019s clinical and\/or commercial prospects; and (iv) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <strong>WHAT THIS MEANS TO SHAREHOLDERS:<\/strong>\u00a0If you suffered a loss in FULC during the relevant timeframe, you have until\u00a0<strong>June 27, 2023<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU:<\/strong>\u00a0If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees.\u00a0Discuss your rights with our legal team without cost or obligation.<\/p>\n<p>\n        <strong>PROTECT YOUR FINANCIAL INTERESTS:<\/strong>\u00a0Complete this brief submission form <a href=\"https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3<\/a> or call 212-363-7500 to discuss the case.<\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY:<\/strong>\u00a0Over the past 20 years, the team at Levi &amp;\u00a0Korsinsky\u00a0has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp;\u00a0Korsinsky\u00a0has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP<br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>55 Broadway, 4th Floor Suite #427<br \/>New York, NY 10006<br \/><a href=\"mailto:jlevi@levikorsinsky.com\" rel=\"nofollow noopener\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/>www.zlk.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTZjZWE2ZTMtYmMyZC00MTk4LWFkYjctMjg1MjMyZjE3MzNiLTEwMzIyOTM=\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in\u00a0Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d or the &#8220;Company&#8221;)\u00a0(NASDAQ: FULC) of a class action securities lawsuit. The lawsuit on behalf of Fulcrum Therapeutics, Inc. investors has been commenced in the United States District Court for New Jersey. Affected investors purchased or otherwise acquired certain Fulcrum securities\u00a0between March 3, 2022 and March 8, 2023. Follow the link below to get more information and be contacted by a member of our\u00a0team: https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3 or contact Joseph E. Levi, Esq. either via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500.\u00a0There is no cost or obligation to you. Fulcrum Therapeutics, Inc. NEWS \u2013 FULC NEWS CASE DETAILS:\u00a0According to the filed complaint, during the class period, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753772","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in\u00a0Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d or the &#8220;Company&#8221;)\u00a0(NASDAQ: FULC) of a class action securities lawsuit. The lawsuit on behalf of Fulcrum Therapeutics, Inc. investors has been commenced in the United States District Court for New Jersey. Affected investors purchased or otherwise acquired certain Fulcrum securities\u00a0between March 3, 2022 and March 8, 2023. Follow the link below to get more information and be contacted by a member of our\u00a0team: https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3 or contact Joseph E. Levi, Esq. either via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500.\u00a0There is no cost or obligation to you. Fulcrum Therapeutics, Inc. NEWS \u2013 FULC NEWS CASE DETAILS:\u00a0According to the filed complaint, during the class period, &hellip; Continue reading &quot;FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T18:42:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\",\"datePublished\":\"2023-05-02T18:42:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"},\"wordCount\":463,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\",\"name\":\"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\",\"datePublished\":\"2023-05-02T18:42:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_locale":"en_US","og_type":"article","og_title":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","og_description":"NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in\u00a0Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d or the &#8220;Company&#8221;)\u00a0(NASDAQ: FULC) of a class action securities lawsuit. The lawsuit on behalf of Fulcrum Therapeutics, Inc. investors has been commenced in the United States District Court for New Jersey. Affected investors purchased or otherwise acquired certain Fulcrum securities\u00a0between March 3, 2022 and March 8, 2023. Follow the link below to get more information and be contacted by a member of our\u00a0team: https:\/\/zlk.com\/pslra-1\/fulcrum-lawsuit-submission-form?wire=3 or contact Joseph E. Levi, Esq. either via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500.\u00a0There is no cost or obligation to you. Fulcrum Therapeutics, Inc. NEWS \u2013 FULC NEWS CASE DETAILS:\u00a0According to the filed complaint, during the class period, &hellip; Continue reading \"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-02T18:42:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline","datePublished":"2023-05-02T18:42:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"},"wordCount":463,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/","name":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=","datePublished":"2023-05-02T18:42:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDI4MCM1NTcwNjM3IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulc-lawsuit-alert-levi-korsinsky-reminds-fulcrum-therapeutics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FULC LAWSUIT ALERT: Levi &amp; Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753772"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}